Nacl Industries Ltd · NSE:NACLIND
Nacl Industries — Q3 FY2021 Earnings Presentation
42 slides from Nacl Industries's earnings presentation, Mar 20, 2021
Slide 1: Investor Presentation submission letter to stock exchanges
A NACL Industries Limited NAGARJUNA NACL Ref: NACL/SE/2020-21 20th March, 2021 1) BSE Limited 2) National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers Exchange Plaza, 5thFloor Dalal Street, Plot No.Cf 1 G Block, Fort, Mumbai, Bandra -Kurla Complex, Bandra (E) Mumbai - 400001 Mumbai-400051.
Slide 2: NACL Industries Limited Investor Presentation Q3 FY 2021
NACL Industries Limited Investor Presentation | Q3 FY 2021
Slide 3: Forward Looking Statement
Forward Looking Statement This presentation contains forward-looking statements, including, but not limited to, the statements and expectations contained in this presentation. Statements herein, other than statements of historical fact, regarding future events or prospects, are forward-looking state
Slide 4: Content
CONTENT Corporate Identity Results Summary Financial Performance Page No: 04 Page No: 09 Page No: 19 Annexure Shareholders’ Information Page No: 25 Page No: 39 NACL Industries Limited 3
Slide 5: Corporate Identity
CORPORATE IDENTITY NACL Industries Limited 4
Slide 6: About NACL
ABOUT NACL o Concern o Commitment o Quality o Integrity NACL is an established agrochemical Company in India, Values founded in 1993. The Company started as an Active Ingredient manufacturer and has built a sizable business in Domestic Retail, B2B and Exports, with many of the customers being large
Slide 7: Quick Facts
QUICK FACTS 5 12,500 53 3 Million Farmers Retailers Branded Products Manufacturing Units ( Customers ) 30 1,184 25+ Years of Experience Geographical Presence Employee Strength NACL Industries Limited 6
Slide 8: Geographical Reach
GEOGRAPHICAL REACH USA 30 Uzbekistan Countries Iran lebanon Nepal 12,500 Egypt Taiwan Retailers Thailand Sudan Jordan India Costa Rica ~32 Yemen Columbia Uganda Ethiopia Ecuador Tanzania Sri Lanka Revenue from International (%) Zambia 03 Paraguay Myanmar Manufacturing Plants Argentin Australia NACL
Slide 9: Product Portfolio
PRODUCT PORTFOLIO Branded Products Portfolio of NACL Includes Insecticides, Herbicides, Fungicides and Plant Growth Regulators. Technicals Insecticides Fungicides Herbicides Profenofos Myclobutanil Pretilachlor Lambda-Cyhalothrin Propiconazole BispyribacSodium Tricyclazole Metribuzin Clodinafop-Prop
Slide 10: Results Summary
RESULTS SUMMARY NACL Industries Limited 9
Slide 11: Result Summary – Q3FY21
RESULT SUMMARY – Q3FY21 (In ₹ lakhs) Revenue EBITDA PAT 26,475 910 2,888 1,792 23,868 309 Q3FY20 Q3FY21 Q3FY20 Q3FY21 Q3FY20 Q3FY21 Revenue Breakup (₹ in lakhs) Plant Growth Regulators & Insecticides Herbicides Fungicides Nematicides 13% 32% 35% 11% Q3FY21 9,127 5,715 10,056 945 Q3FY20 10,503 4,328
Slide 12: Revenue Split – Q3FY21
REVENUE SPLIT – Q3FY21 Q3FY21 Q3FY20 Product Category-wise (%) Product Category-wise (%) Formulation Technical Formulation Technical 7% 6% 22% 21% 26% 40% 45% 47% 48% 58% 20% 24% 23% 13% Insecticides Herbicides Fungicides Plant Growth Regulators & Nematicides Insecticides Herbicides Fungicides Plant
Slide 13: Result Summary – 9MFY21
RESULT SUMMARY – 9MFY21 (In ₹ lakhs) Revenue EBITDA PAT 9,285 86,094 3,315 5,563 73,826 1,077 9MFY20 9MFY21 9MFY20 9MFY21 9MFY20 9MFY21 Revenue Breakup (₹ in lakhs) Plant Growth Regulators & Insecticides Herbicides Fungicides Nematicides 13% 29% 24% 42% Q3FY21 36,430 17,030 28,415 2,214 Q3FY20 32,20
Slide 14: Revenue Split – 9MFY21
REVENUE SPLIT – 9MFY21 9MFY21 9MFY20 Product Category-wise (%) Product Category-wise (%) Formulation Technical Formulations Technical 5% 0.03% 8% 23% 18% 35% 42% 30% 46% 53% 59% 18% 24% 16% 23% Insecticides Herbicides Fungicides Plant Growth Regulators & Nematicides Insecticides Herbicides Fungicide
Slide 15: Profit and Loss – Q3FY21 & 9MFY21 (Standalone)
PROFIT AND LOSS – Q3FY21 & 9MFY21 (Standalone) (₹ in lakhs) Particulars Q3FY21 Q2FY21 Q3FY20 Y-o-Y (%) 9MFY21 9MFY20 Y-o-Y(%) Revenue from operations 26,475 34,417 23,868 11% 86,094 73,826 17% Other income 307 258 187 64% 887 623 42% Total Income 26,782 34,675 24,055 11% 86,981 74,449 17% Expenses C
Slide 16: Result Summary – FY20
RESULT SUMMARY – FY20 (₹ in lakhs) Revenue EBITDA PAT 1,01,489 7,607 1,577 3,941 86,549 FY19 FY20 -838 FY19 FY20 FY19 FY20 Revenue Breakup (₹ in lakhs) Plant Growth Regulators & Insecticides Herbicides Fungicides Nematicides 33% 20% 26% 4% Q3FY21 49,354 16,398 28,918 5,666 Q3FY20 37,192 20,542 22,91
Slide 17: Revenue Split – FY20
REVENUE SPLIT – FY20 FY20 FY19 Product Category-wise (%) Product Category-wise (%) Formulation Technical Formulation Technical 7% 3% 5% 11% 19% 34% 25% 35% 42% 48% 54% 40% 14% 28% 15% 20% Insecticides Herbicides Fungicides Plant Growth Regulators & Nematicides Insecticides Herbicides Fungicides Plan
Slide 18: Historic Quarterly Trend (1/2)
HISTORIC QUARTERLY TREND (1/2) (₹ in lakhs) Revenue from Operations EBITDA and EBITDA Margin 5,000 15.00% 4,259 34,417 12.28% 4,000 10.78% 10.00% 30,172 8.38% 7.57% 7.67% 7.80% 7.45% 7.36% 27,611 27,663 3,000 7.00% 2,888 26,475 25,202 2,383 23,868 2,127 2,044 2,138 5.00% 2,000 1,792 1,546 19,568 1,3
Slide 19: Historic Quarterly Trend (2/2)
HISTORIC QUARTERLY TREND (2/2) (₹ in lakhs) PBT and PBT Margin PAT and PAT Margin 4,000 10.00% 2,500 8.00% 8.42% 2,000 1,869 6.00% 2,921 3,000 5.39% 5.00% 3.35% 3.15% 5.35% 1,500 3.40%4.00% 2.89% 2.53% 2,000 1.76% 1.89% 2.11% 1.80% 2.10% 0.88% 1.28% 910 0.72% 1,432 1,000 2.00% 0.72% 0.63% 644 1,025
Slide 20: Performance Track Record
PERFORMANCE TRACK RECORD NACL Industries Limited 19
Slide 21: Financial Performance (1/2)
FINANCIAL PERFORMANCE (1/2) (₹ in lakhs) Revenue from Operations EBITDA and EBITDA Margin CAGR 5.81% CAGR 0.38% 7,465 7,607 1,01,489 8,000 7,113 6,777 12.00% 86,517 86,549 7,000 10.00% 83,473 6,000 76,514 5,000 9.65% 8.00% 3,941 4,000 8.37% 6.00% 7.66% 7.44% 3,000 4.00% 2,000 4.42% 1,000 2.00% - 0.0
Slide 22: Financial Performance (2/2)
FINANCIAL PERFORMANCE (2/2) (₹ in lakhs) Working Capital Days Net Worth 154 35,053 138 134 131 27,865 22,588 23,500 18,335 79 FY16 FY17 FY18 FY19 FY20 FY16 FY17 FY18 FY19 FY20 ROCE and ROE Debt to Equity (x) 0.28 20.36% 17.57% 15.84% 13.57% 0.20 0.16 14.04% 6.27% 4.90% 4.56% 4.50% 0.09 0.10 -3.01% F
Slide 23: Profit and Loss
PROFIT AND LOSS (₹ in lakhs) Standalone Consolidated Particulars FY20 FY19 Y-o-Y (%) FY20 FY19 Y-o-Y (%) Revenue from operations 101,489 86,549 17% 101,489 86,549 17% Other income 749 2,570 -71% 750 2,572 -71% Total Income 102,238 89,119 15% 102,239 89,121 15% Expenses (a) Cost of materials consumed
Slide 24: Balance Sheet (1/2)
BALANCE SHEET (1/2) (₹ in lakhs) Standalone Consolidated Particulars FY20 FY19 FY20 FY19 ASSETS Non-current assets : (a) Property, plant and equipment 18,291 13,673 18,291 13,673 (b) Right-to-use assets 597 - 597 - (c) Capital work-in-progress 3,482 1,517 3,482 1,517 (d) Intangible assets 174 470 17
Slide 25: Balance Sheet (2/2)
BALANCE SHEET (2/2) (₹ in lakhs) Standalone Consolidated Particulars FY20 FY19 FY20 FY19 EQUITY AND LIABILITIES Equity : (a) Equity share capital 1,926 1,674 1,926 1,674 (b) Other equity 33,127 26,191 33,770 26,739 Total equity 35,053 27,865 35,696 28,413 Non-current liabilities : (a) Financial liab
Slide 26: Annexure
ANNEXURE NACL Industries Limited 25
Slide 27: Timeline (1/2)
TIMELINE (1/2) Started exporting the Project Work on 2nd The 5th Technical products manufactured Technical Manufacturing Manufacturing block from the Technical Block for manufacturing SAP (Enterprise was established Manufacturing Plant Acephate was initiated Resource Planning) 2005 1998 was successf
Slide 28: Timeline (2/2)
TIMELINE (2/2) Increased focus on branded business and crop segment Geographic expansion both in domestic and Zero Liquid Discharge export business (ZLD) Plant was International collaborations with global players commissioned at the Registration approvals in countries in SE Asia and Africa Renamed a
Slide 29: Board of Directors
BOARD OF DIRECTORS Mrs. K Lakshmi Raju Mr. M Pavan Kumar Mr. Sudhakar Kudva Mr. N Vijayaraghavan Mr. Raghavender Mr. Atul Churiwal Chairperson & Non- Managing Director & Independent Director Non-Executive Director Mateti Investor Nominee Executive Director CEO Independent Director Director Mr. Rajes
Slide 30: Key Management Team
KEY MANAGEMENT TEAM Mr. Amit Taparia Dr. B. Saha Mr. Harish Chandra Mr. G. Jagannadha Rao Mr. S. Mani Prasad Mr. M Pavan Kumar Senior VP – SCM, Chief Research & Bijlwan Executive VP – Exports Head – Human Potential Managing Director & Procurement, IT and Development Officer VP – Operations & and Dom
Slide 31: NACL's Business Model
NACL’S BUSINESS MODEL 50+ Branded Products, 47 Technical manufacturing plant NACL stock points and with a production capacity of 12,500 retail outlets across 10,000 metric tons per annum India under the Company’s direct to retail approach A state-of-the-art R&D Formulation unit with Knowledge Delive
Slide 32: Business Strategy
BUSINESS STRATEGY Strengthening and Farmer Centric product Human Development Tap new geographies and Focus on efficient and enhancing global development and sales Initiatives to develop spread distribution network responsible manufacturing collaborations approach leadership skills Aggressive capacit
Slide 33: NACL – A Unique Investment Case
NACL – A UNIQUE INVESTMENT CASE Strong R&D team with the state-of-the-art facility center to develop the cost effective manufacturing processes Strong product portfolio that is spread across Brand Equity based on consistent quality, insecticides, herbicides, fungicides, plant reliability and farmer
Slide 34: Awards and Accolades
AWARDS AND ACCOLADES Best Company of the Year Suraksha Puraskar Best Management Award 2017 NACL’s Srikakulam Unit has NACL’s manufacturing units NACL has been awarded bagged the prestigious situated at Srikakulam and “Best Company of the Year “Suraksha Puraskar” Award Ethakota both situated in Green
Slide 35: Key External Drivers of the Business
KEY EXTERNAL DRIVERS OF THE BUSINESS The agrochemicals market in India is With respect to crop protection chemicals India is expected to register 8% CAGR to reach considered as a net exporter. With many US$ 3.7 billion by FY22 and US$ 4.7 billion Indian agrochemical/crop protection manufacturers by
Slide 36: Research & Development
RESEARCH & DEVELOPMENT Well-defined Quality Management Systems 01 Well equipped and compliant Quality control laboratories at manufacturing sites and R&D 02 Analytical instruments in the Quality control labs are complying with the latest requirements 03 Laboratories manned by qualified and trained m
Slide 37: Production Capacity
PRODUCTION CAPACITY (Srikakulam Unit, AP) (Ethakota Unit, AP) PRODUCTION CAPACITY Liquid 12,000 Formulation Powder 5,600 Formulation Granule 35,475 Formulation Technical Grade 10,000 1 2 NACL Industries Limited 36
Slide 38: Capacity Expansion Plans
CAPACITY EXPANSION PLANS NACL Multichem Private Limited, Ranasthalam CAPACITY NACL Spec-Chem Limited, Dahej, Gujarat CAPACITY Mandal, Srikakulam NACL Spec-Chem Limited, a wholly owned 25,000 subsidiary of NACL is planning to setup a NACL Multichem Private Limited, a wholly owned 38,000 subsidiary of
Slide 39: Sustainability – Environment, Health & Safety
SUSTAINABILITY – ENVIRONMENT, HEALTH & SAFETY 1 Both the manufacturing plants are adequately covered with green belt. State-of-the-art Zero Liquid Discharge (ZLD) plants at Srikakulam and Ethakota. 2 3 Efficient equipment for reduced energy consumption. Manufacturing plants with first aid items / me
Slide 40: Shareholders' Information
SHAREHOLDERS’ INFORMATION NACL Industries Limited 39
Slide 41: Shareholders' Information
SHAREHOLDERS’ INFORMATION Stock Information (as on 04th February 2021) (As on 31st December 2020) Market Capitalization (₹) 809.75 Cr Shareholding Pattern (%) Shares Outstanding 19.62 Cr Free Float 7.09 Cr Symbol (BSE) / (NSE) 524709 / NACLIND 34.51% Stock Performance Chart (as on 04th February 2021
Slide 42: Thank You
NACL Industries Limited Plot No 12-A, C Block, Lakshmi Towers, Nagarjuna Hills, Punjagutta, Hyderabad - 500082, Telangana, India Phone: +91-40 -24405100 Email: info@naclind.com Thank You